PET in vivo generators $^{134}$Ce and $^{140}$Nd on an internalizing monoclonal antibody probe

por Severin, G W, Fonslet, J, Kristensen, L K, Nielsen, C H, Jensen, A I, Kjær, A, Mazar, A P, Johnston, K, Köster, U
Publicado 2022

PET in vivo generators (134)Ce and (140)Nd on an internalizing monoclonal antibody probe

por Severin, G. W., Fonslet, J., Kristensen, L. K., Nielsen, C. H., Jensen, A. I., Kjær, A., Mazar, A. P., Johnston, K., Köster, U.
Publicado 2022

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

por Doñate, F, Juarez, J C, Burnett, M E, Manuia, M M, Guan, X, Shaw, D E, Smith, E L P, Timucin, C, Braunstein, M J, Batuman, O A, Mazar, A P
Publicado 2008

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours

por Cianfrocca, M E, Kimmel, K A, Gallo, J, Cardoso, T, Brown, M M, Hudes, G, Lewis, N, Weiner, L, Lam, G N, Brown, S C, Shaw, D E, Mazar, A P, Cohen, R B
Publicado 2006